Concordance of Blood-Based and Normal Tissue-Based Dihydropyrimidine Dehydrogenase (DPYD) Genotyping. (24th March 2022)

• Record Type: Journal Article
• Authors: Morelli, Cristina; Formica, Vincenzo; Doldo, Elena; Riondino, Silvia; Rofei, Michela; Vergilii, Lorena; Palmieri, Giampiero; Arkenau, Hendrik-Tobias; Roselli, Mario; Orlandi, Augusto
• Is Part Of: Oncologist. Volume 27:Number 5(2022)
• Page Start: e420
• Page End: e421
• Publication Date: 2022-03-24
• Subjects: Oncology -- Periodicals; Tumors -- Periodicals; Cancérologie -- Périodiques; Tumeurs -- Périodiques; Oncology; Tumors; Neoplasms; Electronic journals; Periodicals; Periodicals; 616.994
• DOI: 10.1093/oncolo/oyac057
• Languages: English
• ISSNs: 1083-7159

Abstract

Abstract : In response to the recently published article by Sharma et al, this letter to the editor presents data about the concordance of blood and normal tissue-based evaluation of DPYD genotyping that suggests that pharmacogenetic screening could be contextual to tumor molecular profiling.